Related Experiment Video
Updated: Feb 9, 2026
06:13
The Intra-Aortic Balloon Pump
Published on: February 5, 2021
24.8K
Ambulatory Intra Aortic Balloon Pump in Advanced Heart Failure
Syed Yaseen Naqvi1, Ibrahim G Salama2, Ayhan Yoruk1
1Department of Cardiology, Advanced Heart Transplant Program, University of Rochester Medical Center Rochester, USA.
Cardiac Failure Review
|June 13, 2018
Summary
Mechanical circulatory support devices like intra-aortic balloon pumps (IABP) aid advanced heart failure patients awaiting cardiac transplantation. A subclavian artery approach for IABP insertion may improve patient mobility during this critical pre-transplant period.
Area of Science:
- Cardiology
- Cardiovascular Surgery
- Medical Devices
Background:
- Cardiac transplantation is the definitive treatment for end-stage heart failure.
- Donor heart scarcity leads to prolonged waiting times for transplantation.
- Mechanical circulatory support devices are crucial for stabilizing patients awaiting heart transplants.
Purpose of the Study:
- To review the physiology and evidence supporting intra-aortic balloon pump (IABP) use in advanced congestive heart failure (CHF).
- To evaluate the efficacy and safety of the subclavian artery approach for IABP insertion.
- To highlight the benefits of ambulatory IABP support in pre-transplant patients.
Main Methods:
- Literature review of IABP physiology and clinical applications in advanced CHF.
- Analysis of studies comparing transfemoral and subclavian/axillary artery approaches for IABP insertion.
- Assessment of patient outcomes, including hemodynamic stability and ambulation.
Main Results:
- IABP provides essential hemodynamic support for patients with advanced heart failure.
- The traditional transfemoral approach restricts patient ambulation, potentially causing deconditioning.
- Subclavian/axillary artery IABP insertion facilitates patient ambulation, supporting pre-transplant conditioning.
Conclusions:
- IABP is a vital bridge therapy for advanced heart failure patients awaiting cardiac transplantation.
- The subclavian artery approach offers a significant advantage by enabling patient ambulation.
- This approach may improve the overall condition of patients on the transplant waiting list.
Related Concept Videos
01:29Heart Failure II: Pathophysiology
978
Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
978
01:17Pathophysiology of Heart Failure
3.9K
Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
3.9K
01:27Heart Failure I: Introduction
927
Heart failure refers to a clinical syndrome caused by structural or functional cardiac disorders that prevent the heart from pumping an adequate amount of blood to meet the body's metabolic needs. This condition often arises from myocardial infarction or ischemia, leading to decreased cardiac output, reduced tissue perfusion, impaired gas exchange, fluid volume imbalance, and decreased functional ability.Heart failure can result from disruptions in the mechanisms that regulate cardiac output...
927
01:22Heart Failure VI: Adjunct Therapies
368
Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
368
01:22Heart Failure Drugs: Diuretics
990
Heart failure and kidney perfusion are interconnected in a complex way. Reduced renal perfusion and venous congestion are two significant factors that contribute to renal dysfunction in heart failure. The kidneys, primarily responsible for fluid balance in the body, are adversely affected due to compromised cardiac output and increased venous pressure. In response to reduced renal perfusion, the kidneys activate neurohumoral mechanisms to restore balance. However, these mechanisms can be...
990
01:30Heart Failure V: Medical Management
342
Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
342